A polyvalent hybrid protein elicits antibodies against the diverse allelic types of block 2 in Plasmodium falciparum merozoite surface protein 1

This publication has 44 references indexed in Scilit:

• Tailoring subunit vaccine immunogenicity: Maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1
  Vaccine, 2010
• Regulated maturation of malaria merozoite surface protein‐1 is essential for parasite growth
  Molecular Microbiology, 2010
• Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development
  Proceedings of the National Academy of Sciences, 2010
• Plasmodium falciparumMerozoite Surface Protein 1 (MSP-1)-MSP-3 Chimeric Protein: Immunogenicity Determined with Human-Compatible Adjuvants and Induction of Protective Immune Response
  Infection and Immunity, 2010
• In VitroGrowth-Inhibitory Activity and Malaria Risk in a Cohort Study in Mali
  Infection and Immunity, 2010
• Population diversity and antibody selective pressure to Plasmodium falciparum MSP1 block2 locus in an African malaria-endemic setting
  BMC Microbiology, 2009
• Extreme Polymorphism in a Vaccine Antigen and Risk of Clinical Malaria: Implications for Vaccine Development
  Science Translational Medicine, 2009
• A Diversity-Covering Approach to Immunization with Plasmodium falciparum Apical Membrane Antigen 1 Induces Broader Allelic Recognition and Growth Inhibition Responses in Rabbits
  Infection and Immunity, 2008
• Breadth and Magnitude of Antibody Responses to MultiplePlasmodium falciparumMerozoite Antigens Are Associated with Protection from Clinical Malaria
  Infection and Immunity, 2008
• Malaria Vaccine-Related Benefits of a Single Protein ComprisingPlasmodium falciparumApical Membrane Antigen 1 Domains I and II Fused to a Modified Form of the 19-Kilodalton C-Terminal Fragment of Merozoite Surface Protein 1
  Infection and Immunity, 2007